“Dapagliflozin in Heart Failure With Reduced Ejection Fraction (HFrEF): A Systematic Review of Its Mechanisms and Clinical Effectiveness”. 2025. Journal of Pharmaceutical and Sciences 8 (4): 2339-47. https://doi.org/10.36490/journal-jps.com.v8i4.1121.